Xuezhi Kang Jiaonang (血脂康胶囊)血脂康胶囊

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

红曲是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:红曲Hong Qu。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:红曲-23beb3db成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 血脂康胶囊) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 红曲Hong Qu.

Explore other medicines containing the same ingredient: 红曲 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 血脂康胶囊Recorded Chinese name: 血脂康胶囊
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 0.3g*12粒0.3 g × 12 capsules

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 北京北大维信生物科技有限公司Chinese legal name: 北京北大维信生物科技有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z10950029

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z10950029

Manufacturer

Chinese legal name: 北京北大维信生物科技有限公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep sealed.

Specification

0.3 g × 12 capsules

中文说明书原文Original Chinese source label

批准文号

国药准字Z10950029

生产企业

北京北大维信生物科技有限公司(国产)

功能主治

除湿祛痰,活血化淤,健脾消食。本品用于脾虚痰淤阻滞症的气短、乏力、头晕、头痛、胸闷、腹胀、食少纳呆等;高脂血症;也可用于由高脂血症及动脉粥样硬化引起的心脑血管疾病的辅助治疗。

用法用量

1.口服,一次2粒,一日2次,早晚饭后服用 2.轻、中度患者一日2粒 ,晚饭后服用,或遵医嘱。

不良反应

1.一般耐受性良好,大部分副作用轻微而短暂。
2.本品常见不良反应为肠胃道不适,如胃痛、腹胀、胃部灼热等。
3.偶可引起血清氨基转移酶和肌酸磷酸激酶可逆性升高。
4.罕见乏力、口干、头晕、头痛、肌痛、皮疹、胆囊疼痛、浮肿、结膜充血和泌尿道刺激症状。

禁忌

1.对本品过敏者。
2.活动性肝炎或无法解释的血清氨基转移酶升高者。

注意事项

1.用药期间应定期检查血脂、血清氨基转移酶和肌酸磷酸激酶;有肝病史者服用本品尤其要注意肝功能的监测。
2.在本品治疗过程中,如发生血清氨基转移酶增高达正常高限3倍,或血清肌酸磷酸激酶显著增高时,应停用本品。
3.不推荐孕妇及乳母使用。
4.儿童用药的安全性和有效性尚未确定。

贮藏

密封。

规格

0.3g*12粒

证据Evidence

  • 批准文号: 国药准字Z10950029
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.